Loading…

Hepatitis B virus, hepatitis C virus and human immunodeficiency virus infection in health care workers: a multiple regression analysis of risk factors

A seroprevalence survey of hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV), was conducted using serum samples obtained from 5813 health care workers (HCWs) in five public hospitals in the Latium region of Italy, during the 1985 vaccination campaign against HBV...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of hospital infection 1995-08, Vol.30 (4), p.273-281
Main Authors: Petrosillo, N., Puro, V., Ippolito, G., Nardo, V.Di, Albertoni, F., Chiaretti, B., Rava', L., Sommella, L., Ricci, C., Zullo, G., Bonaventura, M.E., Galli, C., Girardi, E.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A seroprevalence survey of hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV), was conducted using serum samples obtained from 5813 health care workers (HCWs) in five public hospitals in the Latium region of Italy, during the 1985 vaccination campaign against HBV. The seroprevalences of HBV, HCV and HIV were 23·3% [95% confidence interval (CI) = 22·3−24·4%], 2% (95% CI = 1·6−2·4%) and 0·07% (95% CI = 0·001−0·13%), respectively. In a logistic regression model, sex, increasing age, all job categories vs. physicians, dental treatment in the previous six months, and needlestick injury during the previous year were significantly associated with HBV. Conversely, no occupational and community risk factors, but only history of blood transfusion were significantly associated with HCV. Nevertheless, the documented risk of HCV as well as of HIV transmission through percutaneous and mucocutaneous exposure to blood and body fluids should lead to continued efforts to minimize risks of infection by enhancing the compliance of HCWs with vaccination against HBV and adherence to infection control measures, and by introducing safer devices and techniques.
ISSN:0195-6701
1532-2939
DOI:10.1016/0195-6701(95)90262-7